Concepedia

Publication | Closed Access

Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin

33

Citations

25

References

2015

Year

Abstract

This is the first report evaluating rTM administration for TA-TMA compared with previous treatments. Our data suggests that rTM might offer a better clinical outcome in patients with TA-TMA.

References

YearCitations

Page 1